Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New advances in multiple myeloma

D E Reece1

  • 1University of Kentucky, Blood and Marrow Transplant Program, Markey Cancer Center, Lexington 40536-0093, USA.

Current Opinion in Hematology
|November 14, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Canadian perspective on managing multiple myeloma during the COVID-19 pandemic: lessons learned and future considerations.

Current oncology (Toronto, Ont.)·2020
Same author

Pomalidomide desensitization in a patient hypersensitive to immunomodulating agents.

Current oncology (Toronto, Ont.)·2017
Same author

CyBorD induction therapy in clinical practice.

Bone marrow transplantation·2015
Same author

Early relapse after single auto-SCT for multiple myeloma is a major predictor of survival in the era of novel agents.

Bone marrow transplantation·2014
Same author

Bortezomib in multiple myeloma: systematic review and clinical considerations.

Current oncology (Toronto, Ont.)·2014
Same author

Bortezomib in multiple myeloma: a practice guideline.

Clinical oncology (Royal College of Radiologists (Great Britain))·2013

Recent multiple myeloma research reveals insights into pathogenesis, including human herpesvirus-8 infection and cytogenetic abnormalities. New stem cell transplant strategies and bisphosphonates show promise for improved treatment and survival.

Area of Science:

  • Hematology
  • Oncology
  • Virology

Background:

  • Multiple myeloma pathogenesis is complex, with emerging understanding of viral roles and genetic factors.
  • Current treatment strategies for multiple myeloma involve stem cell transplantation and management of bone disease.

Purpose of the Study:

  • To summarize recent advancements in understanding multiple myeloma.
  • To highlight novel therapeutic strategies and supportive care measures.

Main Methods:

  • Review of recent scientific literature on multiple myeloma.
  • Analysis of emerging data on pathogenesis, transplantation, and supportive therapies.

Main Results:

  • Human herpesvirus-8 infection is recognized for its potential role in multiple myeloma.

Related Experiment Videos

  • Cytogenetic abnormalities in multiple myeloma are being further characterized.
  • Immunotherapeutic techniques are being developed to optimize stem cell transplantation outcomes.
  • Bisphosphonates demonstrate efficacy in preventing bone destruction and potentially improving survival.

    • Conclusions:

    • Advances in understanding multiple myeloma pathogenesis are paving the way for targeted therapies.
    • Optimized stem cell transplantation and bisphosphonate use represent significant progress in patient care.
    • Further research into viral links and cytogenetics may yield new treatment avenues.